Practical guidelines for the supplementation of vitamin D and the treatment of defcits in Central Europe - Recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency

Endokrynologia Polska

Volumn 64, Issue 4, 2013, Pages 319-327

  Płudowski, Paweł ^a   Karczmarewicz, Elzbieta ^a   Bayer, Milan ^b   Carter, Graham ^c   Chlebna Sokół, Danuta ^d   Czech Kowalska, Justyna ^a   Dȩbski, Romuald ^e   Decsi, Tamas ^f   Dobrzańska, Anna ^a   Franek, Edward ^g   Głuszko, Piotr ^h,i   Grant, William B ^j   Holick, Michael F ^k   Yankovskaya, Liudmila ^l   Konstantynowicz, Jerzy ^m   Ksia̧zyk, Janusz B ^a   Ksiȩzopolska Orłowska, Krystyna ^h   Lewiński, Andrzej ^d   Litwin, Mieczysław ^a   Lohner, Szimonetta ^e   Lorenc, Roman S ^a   Łukaszkiewicz, Jacek ⁿ   Marcinowska Suchowierska, Ewa ^e   Milewicz, Andrzej ^o   Misiorowski, Waldemar ^e   Nowicki, Michał ^d   Povoroznyuk, Vladyslav ^p   Rozentryt, Piotr ^q   Rudenka, Ema ^r   Shoenfeld, Yehuda ^s   Socha, Piotr ^a   Solnica, Bogdan ^t   Szalecki, Mieczysław ^a,u   Tałałaj, Marek ^e   Varbiro, Szabolcs ^v   Zmijewski, Michał A ^w   more..

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^b CHARLES UNIVERSITY   (Czech Republic)

^c CHARING CROSS HOSPITAL   (United Kingdom)

^d MEDICAL UNIVERSITY OF LODZ   (Poland)

^e MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^f UNIVERSITY OF PÉCS   (Hungary)

^g POLISH ACADEMY OF SCIENCES   (Poland)

^h INSTITUTE OF RHEUMATOLOGY   (Poland)

ⁱ ANDRZEJ FRYCZ MODRZEWSKI KRAKOW UNIVERSITY   (Poland)

^j Sunlight   (United States)

^k BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^l GRODNO STATE MEDICAL UNIVERSITY   (Belarus)

^m MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

ⁿ MEDICAL UNIVERSITY OF WARSAW   (Poland)

^o WROCLAW MEDICAL UNIVERSITY   (Poland)

^p INSTITUTE OF GERONTOLOGY   (Ukraine)

^q MEDICAL UNIVERSITY OF SILESIA   (Poland)

^r BELARUSIAN MEDICAL ACADEMY OF POSTGRADUATE EDUCATION   (Belarus)

^s TEL AVIV UNIVERSITY   (Israel)

^t JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^u Faculty of Health Science UJK   (Poland)

^v SEMMELWEIS UNIVERSITY   (Hungary)

^w MEDICAL UNIVERSITY OF GDANSK   (Poland)

more..

Author keywords

25 hydroxyvitamin D; Central Europe; General population guidelines; Risk groups; Supplementatio; Vitamin D deficiency

Indexed keywords

VITAMIN D;

ARTICLE; BREAST FEEDING; EUROPE; HEALTH PRACTITIONER; HIGH RISK POPULATION; HUMAN; NUTRITIONAL STATUS; PHYSICIAN; POLAND; PRACTICE GUIDELINE; PREGNANT WOMAN; RECOMMENDED DRUG DOSE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN INTAKE; ADOLESCENT; ADULT; AGE; AGED; CHILD; DIET SUPPLEMENTATION; FEMALE; HEALTH PROMOTION; INFANT; MASS SCREENING; MIDDLE AGED; NEWBORN; ORGANIZATION AND MANAGEMENT; OSTEOPOROSIS, POSTMENOPAUSAL; PREGNANCY; PREGNANCY COMPLICATIONS; PRESCHOOL CHILD; PROCEDURES;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; CHILD, PRESCHOOL; DIETARY SUPPLEMENTS; EUROPE; FEMALE; HEALTH PROMOTION; HUMANS; INFANT; INFANT, NEWBORN; MASS SCREENING; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; POLAND; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84884925671     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: 10.5603/EP.2013.0012     Document Type: Article

References (49)

1. Holick MF Resurrection of vitamin D deficiency and rickets. J Clin Invest 2006; 116: 2062-2072. (Pubitemid 44162310)
2. Garland CF, French CB, Baggerly LL et al. Vitamin D supplement doses and serum 25-hydroxyvitamin D in the range associated with cancer prevention. Anticancer Res 2011; 31: 617-622.
3. Garland CF, Gorham ED, Mohr SB et al. Vitamin D for cancer prevention: Global perspective. Ann Epi 2009; 19: 468-483.
4. Grant WB. Relation between prediagnostic serum 25-hydroxyvitamin D level and incidence of breast, colorectal, and other cancers. J Photochem PhotobiolB: Biol, 2010; 101: 130-136.
5. Anderson JL, May HT, Horne BD et al. for the Intermountain Heart Collaborative (IHC) Study Group: Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 2010; 106: 963-968.
6. Wang L, Song Y, Manson JE et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: A meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes 2012; 1; 5: 819-829.
7. Pilz S, Tomaschitz A, Marz W et al. Vitamin D, cardiovascular disease and mortality. Clin Endocrinol (Oxf) 2011; 75: 575-584.
8. Mini J, Muraru MD, Pittas AG Vitamin D and type 2 diabetes: a systematic review. Eur J Clin Nutr 2011; 65: 1005-1015.
9. Khan H, Kunutsor S, Franco OH et al. Vitamin D, type 2 diabetes and other metabolic outcomes: a systematic review and meta-analysis of prospective studies. Proc Nutr Soc 2012; 30: 1-9.
10. Pittas AG, Nelson J, Mitri J et al. Diabetes Prevention Program Research Group. Plasma 25-hydroxyvitamin D and progression to diabetes in patients at risk for diabetes: an ancillary analysis in the Diabetes Prevention Program. Diabetes Care 2012; 35: 565-573.
11. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens 2007; 20: 713-719. (Pubitemid 46936167)
12. Pittas AG, Chung M, Trikalinos T et al. Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med 2010; 152: 307-314.
13. Burgaz A, Orsini N, Larsson SC et al. Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis. J Hypertens 2011; 29: 636-645.
14. Littorin B, Blom P, Schölin A et al. Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia 2006; 49: 2847-2852. (Pubitemid 44730286)
15. Raghuwanshi A, Joshi SS, Christakos S. Vitamin D and multiple sclerosis. J Cell Biochem 2008; 105: 338-343.
16. Pappa HM, Gordon CM, Saslowsky TM et al. Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics 2006; 118: 1950-1961. (Pubitemid 46393676)
17. Hyppönen E., Boucher BJ, Berry D.J., Power C: 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes 2008; 57: 298-305.
18. Boucher BJ. Is vitamin D status relevant to metabolic syndrome? Der-matoendocrinol 2012; 4: 212-224.
19. Hewison M. Vitamin D and immune function: autocrine, paracrine or endocrine? Scand J Clin Lab Invest (Suppl.) 2012; 243: 92-102.
20. Llewellyn DJ, Lang IA, Langa KM et al. Vitamin D and risk of cognitive decline in elderly persons. Arch Intern Med 2010; 170: 1135-1141.
21. Charzewska J, Chlebna-Sokol D, Chybicka A et al. Prophylaxis of vitamin D deficiency-Polish recommendatio. 2009. Endokrynol Pol 2010; 61: 228-232.
22. Takacs I, Benko I, Toldy E et al. Hungarian consensus regarding the role of vitamin D in the prevention and treatment of diseases. Orv Hetil 2012; 153 (Suppl.): 5-26.
23. German Nutrition Society. New reference values for vitamin D. Ann Nutr Metab 2012; 60: 214-246.
24. IOM (Institute of Medicine): Dietary reference intakes for calcium and vitamin D. Washington (DC): National Academies Press (US). 2011.
25. Holick MF, Binkley NC, Bischoff-Ferrari HA et al., Endocrine Society: Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 1911-1930.
26. Dawson-Hughes B., Mithal A, Bonjour JP et al. IOF position statement: vitamin D recommendations for older adults. Osteoporos Int 2010; 21: 1151-1154.
27. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA): Scientific opinion on the tolerable upper intake level of vitamin D. EFSA Journal 2012; 10: 2813: 1-45.
28. Holick MF. Vitamin D and sunlight: strategies for cancer prevention and other health benefits. Clin J Am Soc Nephrol 2008; 3: 1548-1554.
29. Krzyscin JW, Jaroslawski J, Sobolewski PS A mathematical model for seasonal variability of vitamin D due to solar radiation. J Photochem Photobiol B 2011; 5; 105: 106-112.
30. Mason RS, Reichrath J. Sunlight Vitamin D and Skin Cancer. Anticancer Agents Med Chem 2013; 13: 83-97.
31. Kavathia D, Buckley JD, Rao D et al. Elevated 1, 25-dihydroxyvitamin D levels are associated with protracted treatment in sarcoidosis. Respir Med 2010; 104: 564-570.
32. Schlingmann KP, Kaufmann M, Weber S et al. Mutations of CYP24A1 and Idiopathic Infantile Hypercalcemia. New Engl J Med 2011; 365: 410-421.
33. Singh RJ, Taylor RL, Reddy GS et al. C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J Clin Endocrinol Metab 2006; 91: 3055-3061. (Pubitemid 44271755)
34. Lensmeyer G, Poquette M, Wiebe D et al. The C-3 epimer of 25-hydroxyvitamin D3 is present in adult serum. J Clin Endocrinol Metab 2012; 97: 163-168.
35. Sanders KM, Stuart AL, Williamson EJ et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 2010; 12; 303: 1815-1822.
36. Grant WB. Effect of interval between serum draw and follow-up period on relative risk of cancer incidence with respect to 25-hydroxyvitamin D level; implications for meta-analyses and setting vitamin D guidelines. Dermatoendocrinol 2011; 3: 199-204.
37. Grant WB. Effect of follow-up time on the relation between prediagnostic serum 25-hydroxyitamin D and all-cause mortality rate. Dermatoendocrinol 2012; 4: 198-202.
38. Grant WB. Ecological studies of the UVB-vitamin D-cancer hypothesis. Anticancer Res 2012; 32: 223-236.
39. Lin SW, Wheeler DC, Park Y et al. Prospective study of ultraviolet radiation exposure and risk of cancer in the U.S. Int J Cancer 2012; 131: E1015-1023.
40. Cannell JJ, Vieth R, Umhau JC et al. Epidemic influenza and vitamin D. Epidemiol Infect 2006; 134: 1129-1240.
41. Grant WB. Role of solar UV irradiance and smoking in cancer as inferred from cancer incidence rates by occupation in Nordic countries. Derma-toendocrinol 2012; 4: 203-211.
42. Lappe JM, Heaney RP Why randomized controlled trials of calcium and vitamin D sometimes fail. Dermatoendocrinol 2012; 4: 95-100.
43. Bischoff-Ferrari H.A., Willett WC, Orav EJ et al. A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med 2012; 367: 40-49.
44. Lappe JM, Travers-Gustafson D, Davies KM et al. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007; 85: 1586-1591. (Pubitemid 46890428)
45. Urashima M, Segawa T, Okazaki M et al. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr 2010; 91: 1255-1260.
46. Grant WB. A review of the evidence regarding the solar ultraviolet-B-vitamin D-cancer hypothesis. Standardy Med 2012; 9: 610-619.
47. Slinin Y, Paudel M, Taylor BC et al. Study of Osteoporotic Fractures Research Group: Association between serum 25(OH) vitamin D and the risk of cognitive decline in older women. J Gerontol A Biol Sci Med Sci 2012; 67: 1092-1098.
48. Zittermann A, Iodice S, Pilz S et al. Vitamin D deficiency and mortality risk in the general population: A meta-analysis of prospective cohort studies. Am J Clin Nutr 2012; 95: 91-100.
49. Sabetta JR, DePetrillo P, Cipriani RJ et al. Serum 25-hydroxyvitamin D and the incidence of acute viral respiratory tract infections in healthy adults. PLoS One 2010; 5: e11088.